«Neurological disorders present all sorts of challenges that range from the screening of people who may have a particular disease to the monitoring of patients in their homes. PharmStars, a digital health accelerator program, has graduated a new group of startups that are developing potential new solutions.»

«PharmStars focuses on mentoring startups that use digital technologies to address some challenge or problem facing the pharmaceutical industry. Each cohort of startups is formed around a particular theme. Innovations in neurological disease was the theme for the most recent group of accelerator participants.
Startups that are part of PharmStars take part in a 10-week program. Classes teach them about the pharma industry. Participants also have the opportunity to meet with representatives from big pharmaceutical companies, who provide mentoring. These pharma companies don’t select the startups for each cohort but they do provide input on the themes. Pharma company members of the accelerator include Takeda Pharmaceutical, Novo Nordisk, Eli Lilly and Boehringer Ingelheim.»

Article written by Frank Vinluan.



MedCity News